We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Molecular Devices to attend ADME & Predictive Toxicology Europe
News

Molecular Devices to attend ADME & Predictive Toxicology Europe

Molecular Devices to attend ADME & Predictive Toxicology Europe
News

Molecular Devices to attend ADME & Predictive Toxicology Europe

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Molecular Devices to attend ADME & Predictive Toxicology Europe"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The SpectraMax® Paradigm® Multi-Mode Microplate Detection Platform is the only user upgradeable microplate reader on the market that allows for real-time system configuration by the user in less than two minutes. This revolution in modularity allows you to read what you want, when you want without compromising your biology. Although your detection needs may change, your equipment can stay the same simply by adding a new detection cartridge. Cartridges include TUNE, Absorbance, HTRF, AlphaScreen® and Fluorescence intensity.

SpectraMax® microplate readers are ideal for increased throughput of early ADME compound profiling assays such as the Transil® Membrane Affinity Assay and Human Serum Albumin Binding Assay. The Membrane Affinity assay provides high-throughput lipophilicity data equivalent to liposome-based methods without the need for ultracentrifugation. The Human Serum Albumin Binding assay provides high-throughput blood protein binding data by measuring the fraction bound to Human Serum Albumin.

Advertisement